Sanders C C, Sanders W E
Antimicrob Agents Chemother. 1979 Jun;15(6):792-7. doi: 10.1128/AAC.15.6.792.
Selection of resistance to cefamandole has been observed, and the drug has failed to protect animals lethally infected with certain Enterobacteriaceae that appeared to be highly susceptible in vitro. Using spectrophotometric assays, some of these organisms were found to produce beta-lactamases highly active against cefamandole. Cefoxitin, a poor enzyme substrate, was found to be superior to both cephalothin and cefamandole in induction of these enzymes. A simple disk induction test was developed and used to examine 147 Enterobacteriaceae for production of these beta-lactamases. The enzymes were found in 69% of cephalothin-resistant, cefamandole-susceptible strains and in only 3% of strains susceptible to both cephalothin and cefamandole. They were most prevalent among isolates of Enterobacter, indole-positive Proteus, and Serratia. Since selection of resistance and therapeutic failures have occurred most often among these genera, the relationship between presence of inducible enzymes and outcome of therapy should be examined further in humans.
已观察到对头孢孟多产生耐药性的情况,并且该药物未能保护受到某些在体外似乎高度敏感的肠杆菌科细菌致死性感染的动物。通过分光光度法测定,发现其中一些微生物产生了对头孢孟多具有高活性的β-内酰胺酶。头孢西丁是一种较差的酶作用底物,在诱导这些酶方面被发现优于头孢噻吩和头孢孟多。开发了一种简单的纸片诱导试验,并用于检测147株肠杆菌科细菌是否产生这些β-内酰胺酶。在69%的对头孢噻吩耐药但对头孢孟多敏感的菌株中发现了这些酶,而在对头孢噻吩和头孢孟多均敏感的菌株中仅3%发现了这些酶。它们在肠杆菌属、吲哚阳性变形杆菌属和沙雷菌属的分离株中最为普遍。由于在这些菌属中最常出现耐药性的选择和治疗失败的情况,因此应在人体中进一步研究诱导酶的存在与治疗结果之间的关系。